The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin | MicrobiomeTrials← Back to trialsNCT06223685
The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-04-01Est. Completion: 2024-08-01
Enrollment target: 129 participants Locations- Sonomed CENTRUM MEDYCZNE, Szczecin, West Pomeranian Voivodeship, Poland
Other microbiome trials you might be interested in
Functional Somatic DisorderSomatic Symptom Disorder
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chro…
Stockholm, SwedenCompleted Jun 1, 2024
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Completed
Functional Somatic DisorderSomatic Symptom DisorderFunctional Somatic Syndromes
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chro…
Stockholm, SwedenCompleted Jan 1, 2025